Fig. 9.
Study on the neuroprotective effects of the selected compounds on the SHSY5Y cell line. A, B Cell viability of adapalene and ranolazine on SH-SY5Y cells. C Adapalene and ranolazine enhance cell viability in SHSY5Y Cells subjected to OGD/R. ap < 0.05 compared to control, bp < 0.05 compared to OGD/R, cp < 0.05 compared to OGD/R + 5 μM ADA, dp < 0.05 compared to OGD/R + 10 μM ADA, ep < 0.05 compared to OGD/R + 20 μM ADA, fp < 0.05 compared to OGD/R + 5 μM RAN, gp < 0.05 compared to OGD/R + 10 μM RAN, and.hp < 0.05 compared to OGD/R + 20 μM RAN in their respective groups. All values are represented in the form of mean ± SD (n = 4). (One-way ANOVA followed by Tukey’s multiple comparison post hoc test)
